Company ImmunoGen, Inc.
Equities
IMGN
US45253H1014
Biotechnology & Medical Research
Business Summary
Number of employees: 277
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Enyedy
CEO | Chief Executive Officer | 60 | 16-05-15 |
Lauren White
DFI | Director of Finance/CFO | 45 | 23-09-17 |
Robert Herbst
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 23-01-03 | |
Anabel Chan
IRC | Investor Relations Contact | - | - |
Isabel Kalofonos
PRN | Corporate Officer/Principal | 53 | 23-04-23 |
Renee Lentini
AUD | Comptroller/Controller/Auditor | 46 | 03-12-31 |
Stacy Coen
PRN | Corporate Officer/Principal | 53 | 20-06-02 |
Joseph J. Kenny
LAW | General Counsel | - | 08-12-31 |
Audrey Bergan
HRO | Human Resources Officer | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Enyedy
CEO | Chief Executive Officer | 60 | 16-05-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 279,354,016 | 279,140,089 ( 99.92 %) | 0 | 99.92 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |